Development and validation of an ultra‐performance liquid chromatography–tandem mass spectrometry method for the determination of baloxavir in rat plasma and its application to pharmacokinetic studies
Biomedical Chromatography · 2023
DOI: 10.1002/bmc.5729 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2023. Verfasst von Hongli Mu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research Center, Central Hospital Affiliated to Shandong First Medical University, Jinan, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Triazines, Dibenzothiepins, Oxazoles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: The National Science and Technology Major Project of China, The Jinan Technology Development Program, National Science and Technology Major Project.
Abstract (Originalsprache)
In this study, an ultra‐performance liquid chromatography–tandem mass spectrometry method was established for the development and validation of baloxavir acid (BXA) concentrations and the active ingredients of the antiviral drug baloxavir marboxil (BXM). Further, the method was applied to study the pharmacokinetics of BXA. BXA was determined by the electrospray ionization multiple reaction monitoring positive ion mode, and the mass‐to‐charge ratios ( m/z ) of BXA and internal standard baloxavir‐d4 were 484.2 → 247.2 and 488.1 → 247.2. An Oasis max online column (2.1 × 20 mm, 30 μm) was used with 1% formic acid in water (A) and 2% formic acid in acetonitrile (B) as mobile phases at a flow rate of 0.5 mL·min −1 for chromatographic separation. The linearity was good in the range of 3–200 ng·mL −1 (r = 0.9994), with 3.00 ng·mL −1 lower limit of quantification. The relative standard deviation of the inter‐assay precision was less than or equal to 6.51%, and the accuracy was in the range of 91.28%–104.29%. This method is suitable for the determination of BXA and for performing pharmacokinetic studies in clinical research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Research Center, Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
- Animal Laboratory, Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
ORCID-Profile: Hengli Zhao, Qing Wen
Förderung
- The National Science and Technology Major Project of China
- The Jinan Technology Development Program
- National Science and Technology Major Project
Zitieren
APA
Mu, H., Zhang, W., Song, Y., Liang, R., Zhao, H., Song, C., & Wen, Q. (2023). Development and validation of an ultra‐performance liquid chromatography–tandem mass spectrometry method for the determination of baloxavir in rat plasma and its application to pharmacokinetic studies. Biomedical Chromatography. https://doi.org/10.1002/bmc.5729
Vancouver
Mu H, Zhang W, Song Y, Liang R, Zhao H, Song C, et al. Development and validation of an ultra‐performance liquid chromatography–tandem mass spectrometry method for the determination of baloxavir in rat plasma and its application to pharmacokinetic studies. Biomedical Chromatography. 2023. doi:10.1002/bmc.5729
BibTeX
@article{Mu2023,
author = {Mu, Hongli and Zhang, Wenyu and Song, Yuanming and Liang, Rui and Zhao, Hengli and Song, Chunhong and Wen, Qing},
title = {Development and validation of an ultra‐performance liquid chromatography–tandem mass spectrometry method for the determination of baloxavir in rat plasma and its application to pharmacokinetic studies},
journal = {Biomedical Chromatography},
year = {2023},
doi = {10.1002/bmc.5729}
}
EUVIMED